Evidence map›Paper›PMID 30996161›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole.

Takashi Yoshida, Takuto Tachita, Haruna Fujinami, Yoshiko Oshima, Hirokazu Sasaki, Yoshiaki Marumo, Tomoko Narita, Asahi Ito, Masaki Ri, Shigeru Kusumoto and 3 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Pathogens (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. IDCases · 2022
    Article
  10. Exophiala dermatitidis.World journal of clinical cases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Takashi YoshidaDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Takuto TachitaDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Haruna FujinamiDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Yoshiko OshimaDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Hirokazu SasakiDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Yoshiaki MarumoDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Tomoko NaritaDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Asahi ItoDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Masaki RiDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Shigeru KusumotoDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Takashi IshidaDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Hirokazu KomatsuDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Shinsuke IidaDivision of Hematology & Oncology, Nagoya City University Hospital, Japan.
Nagoya City University Hospital · JPNagoya Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases, including those caused by fungi, remain important issues in patients receiving malignant lymphoma chemotherapy. We herein report a rare case of Exophiala dermatitidis fungemia during chemotherapy in a 67-year-old woman admitted to our hospital. She had a fever that could not be resolved despite antifungal therapy. Yeast-like fungi were detected in blood culture samples, but biochemical identification was difficult. E. dermatitidis, a black mold, was identified using time-of-flight mass spectrometry. The patient finally improved after her treatment was switched to voriconazole. Fungal infection is difficult to diagnose and treat, but this novel approach can improve patients' outcomes.

Indexed as

ExophialaAgedAntifungal AgentsAntineoplastic Combined Chemotherapy ProtocolsFemaleFungemiaHumansLymphomaMass SpectrometryVoriconazoleAntifungal AgentsVoriconazole(2 to 6): malignant lymphomaExophiala dermatitidismass spectrometryvoriconazole

Identifiers

PMID30996161
PMCPMC6709338
OpenAlexW2937466951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.